Nonenzymatic galactosylation of human LDL decreases its metabolism by human skin fibroblasts.
D001053:Apolipoproteins / Q000378:metabolism; D001055:Apolipoproteins B; D002478:Cells, Cultured; D003920:Diabetes Mellitus / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism*; D005690:Galactose; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000378:metabolism; D011973:Receptors, LDL; D012867:Skin / Q000378:metabolism
D001053:Apolipoproteins; D001055:Apolipoproteins B; D008077:Lipoproteins, LDL; D011956:Receptors, Cell Surface; D011973:Receptors, LDL; D005690:Galactose